Morrison Foerster expands with trio of litigators

The firm adds three partners to its New York office | Expansion brings a combined 60 years of experience | Hires experienced in high-stakes patent disputes involving biologics, small-molecule drugs, and medical devices.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Careers

Dechert boosts litigation bench with partner duo

25 March 2026 Two senior hires from a rival firm bring litigation expertise across life sciences and tech disputes.

Careers

US firm boosts patent bench with Desmarais hire

18 March 2026 A new partner hire at the firm brings rare depth across both the ITC and district courts in technology and life sciences.

Careers

HSF Kramer hires patent litigator as partner in Germany

17 March 2026 New recruit, who has worked on more than 150 infringement cases, will join the firm’s disputes practice in Düsseldorf and strengthen its UPC offering.

More features

UPC appeals court upholds Abbott injunction in glucose monitoring patent dispute

CRISPR priority feud ends at USPTO as board reaches decision

Novartis bets $2bn on biologics as Xolair patents fade

WIPR debuts Global In-House Elite 2026

mRNA litigation: Who’s winning, who’s filing, and what’s next

Dechert boosts litigation bench with partner duo

UK court deals blow to Spanish pharma’s SPC bid for contraceptive

EPO reports record patent filings, but pharma and biotech lag

Morrison Foerster expands with trio of litigators

More on this story

Editor's picks

Editor's picks

More features